PBH - Prestige Consumer Healthcare Inc.
NEXT EARNINGS:
May 14, 2026
EPS Est: $1.43
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$66.00
DETAILS
HIGH:
$66.00
LOW:
$66.00
MEDIAN:
$66.00
CONSENSUS:
$66.00
DOWNSIDE:
4.06%
Market Cap:
3.31B
Volume:
556,288
Avg Volume:
413,590
52 Week Range:
57.25-90.04
Sector:
Healthcare
Industry:
Medical - Distribution
Beta:
0.42
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
600
IPO Date:
2005-02-10
EPS (TTM):
4.32
P/E Ratio:
19.91
Revenue (TTM):
1.14B
Total Assets:
3.40B
Total Debt:
1.04B
Cash & Equiv:
97.88M
Rev Growth (5Y):
3.4%
EPS Growth (5Y):
9.0%
FCF Growth (5Y):
3.7%
ROCE:
10.1%
Debt/Equity:
0.57
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-05 | $1.14 | $1.16 | -1.7% | $283.4M | $297.1M | -4.6% |
| 2025-11-06 | $1.07 | $0.97 | +10.3% | $274.1M | $294.2M | -6.8% |
| 2025-08-07 | $0.95 | $1.01 | -5.9% | $249.5M | $275.0M | -9.3% |
| 2025-05-08 | $1.32 | $1.30 | +1.5% | $296.8M | $270.4M | +9.7% |
| 2025-02-06 | $1.22 | $1.16 | +5.2% | $290.3M | $289.8M | +0.2% |
| 2024-11-07 | $1.09 | $1.08 | +0.9% | $283.5M | $282.1M | +0.5% |
| 2024-08-08 | $0.90 | $0.86 | +4.7% | $267.1M | $260.5M | +2.5% |
| 2024-05-14 | $0.98 | $1.14 | -14.0% | $277.0M | $287.4M | -3.6% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.14B | 1.13B | 1.13B | 1.09B | 943.37M | 963.01M | 975.78M | 1.04B | 882.06M | 806.25M | 714.62M | 601.88M |
| Net Income | 214.60M | 209.34M | (82.31M) | 205.38M | 164.68M | 142.28M | (35.80M) | 339.57M | 69.39M | 99.91M | 78.26M | 72.61M |
| EPS | 4.32 | 4.21 | -1.65 | 4.09 | 3.28 | 2.81 | -0.69 | 6.34 | 1.31 | 1.89 | 1.50 | 1.41 |
| Total Assets | 3.40B | 3.32B | 3.35B | 3.67B | 3.43B | 3.51B | 3.44B | 3.76B | 3.91B | 2.95B | 2.67B | 1.80B |
| Total Debt | 1.04B | 1.14B | 1.37B | 1.51B | 1.51B | 1.77B | 1.80B | 1.99B | 2.19B | 1.63B | 1.59B | 934.41M |
| Cash & Equivalents | 97.88M | 46.47M | 58.49M | 27.18M | 32.30M | 94.76M | 27.53M | 32.55M | 41.85M | 27.23M | 21.32M | 28.33M |
| Operating Cash Flow | 251.51M | 248.93M | 229.72M | 259.92M | 235.61M | 217.12M | 189.28M | 210.11M | 147.77M | 174.35M | 156.25M | 111.58M |
| Free Cash Flow | 243.29M | 239.38M | 221.93M | 250.28M | 213.36M | 202.56M | 178.80M | 197.58M | 144.79M | 170.78M | 150.15M | 108.82M |
| FCF per Share | 4.90 | 4.81 | 4.45 | 4.98 | 4.25 | 3.99 | 3.45 | 3.72 | 2.73 | 3.24 | 2.88 | 2.11 |
| Book Value | 1.83B | 1.66B | 1.45B | 1.58B | 1.36B | 1.17B | 1.10B | 1.18B | 822.55M | 744.34M | 627.62M | 563.36M |
| Cash & ST Investments | 97.88M | 46.47M | 58.49M | 27.18M | 32.30M | 94.76M | 27.53M | 32.55M | 41.85M | 27.23M | 21.32M | 28.33M |
| ROC Equity | 0.12 | 0.13 | -0.06 | 0.13 | 0.12 | 0.12 | -0.03 | 0.29 | 0.08 | 0.13 | 0.12 | 0.13 |